RBC Life Sciences, Inc. (RBCL)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jul 8, 2025
RBC Life Sciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | 2005 - 2009 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '15 Sep 30, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | Dec '11 Dec 31, 2011 | Dec '10 Dec 31, 2010 | 2005 - 2009 |
Net Income | -0.56 | -0.6 | -0.5 | -0.36 | -0.07 | 0.56 | Upgrade |
Depreciation & Amortization | 0.52 | 0.58 | 0.59 | 0.58 | 0.51 | 0.54 | Upgrade |
Loss (Gain) From Sale of Assets | -1.71 | - | 0 | - | -0.01 | 0.02 | Upgrade |
Stock-Based Compensation | 0 | 0 | 0.02 | 0.04 | 0.04 | 0.06 | Upgrade |
Other Operating Activities | -0.13 | -0.13 | -0.24 | -0.33 | -0.05 | 0.1 | Upgrade |
Change in Accounts Receivable | 0.07 | -0.38 | -0.03 | -0.29 | -0.09 | 0.08 | Upgrade |
Change in Inventory | -0.11 | 0.32 | -0.07 | 1.38 | -1.11 | 0.01 | Upgrade |
Change in Accounts Payable | -1.73 | 0.71 | 0.12 | -0.63 | 0.06 | 0.3 | Upgrade |
Change in Unearned Revenue | 0.01 | -1.53 | 0.45 | 0.24 | 0.5 | -1.18 | Upgrade |
Change in Other Net Operating Assets | 0.72 | 0.42 | -0.05 | -0.17 | 0.35 | 0.05 | Upgrade |
Operating Cash Flow | -2.9 | -0.61 | 0.29 | 0.45 | 0.13 | 0.54 | Upgrade |
Operating Cash Flow Growth | - | - | -33.93% | 255.44% | -77.00% | 244.07% | Upgrade |
Capital Expenditures | -0.38 | -1.07 | -0.27 | -0.81 | -0.35 | -0.16 | Upgrade |
Sale of Property, Plant & Equipment | 4.82 | - | - | - | 0.01 | 0.01 | Upgrade |
Other Investing Activities | - | - | - | 0.63 | - | - | Upgrade |
Investing Cash Flow | 4.48 | -1.07 | -0.27 | -0.18 | -0.35 | -0.16 | Upgrade |
Long-Term Debt Repaid | - | -0.21 | -0.2 | -0.18 | -0.17 | -0.16 | Upgrade |
Total Debt Repaid | -1.19 | -0.21 | -0.2 | -0.18 | -0.17 | -0.16 | Upgrade |
Net Debt Issued (Repaid) | -1.19 | -0.21 | -0.2 | -0.18 | -0.17 | -0.16 | Upgrade |
Issuance of Common Stock | - | - | - | - | - | 0.04 | Upgrade |
Repurchase of Common Stock | - | - | -0.02 | - | - | - | Upgrade |
Financing Cash Flow | -1.19 | -0.21 | -0.21 | -0.18 | -0.17 | -0.11 | Upgrade |
Foreign Exchange Rate Adjustments | 0.31 | 0.07 | 0.04 | -0.05 | 0.03 | -0.03 | Upgrade |
Net Cash Flow | 0.69 | -1.82 | -0.15 | 0.04 | -0.36 | 0.25 | Upgrade |
Free Cash Flow | -3.29 | -1.68 | 0.03 | -0.36 | -0.23 | 0.38 | Upgrade |
Free Cash Flow Margin | -13.63% | -5.95% | 0.11% | -1.43% | -0.79% | 1.35% | Upgrade |
Free Cash Flow Per Share | -1.49 | -0.76 | 0.01 | -0.16 | -0.10 | 0.17 | Upgrade |
Cash Interest Paid | 0.1 | 0.1 | 0.11 | 0.13 | 0.14 | 0.15 | Upgrade |
Cash Income Tax Paid | 0.04 | 0.04 | -0.17 | -0.12 | -0.24 | 0 | Upgrade |
Levered Free Cash Flow | -2.59 | -1.16 | 0.47 | -0.36 | -0.36 | 0.39 | Upgrade |
Unlevered Free Cash Flow | -2.55 | -1.1 | 0.54 | -0.28 | -0.27 | 0.48 | Upgrade |
Change in Net Working Capital | 1.28 | 0.22 | -0.59 | -0.47 | 0.43 | 0.6 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.